参考文献

2020-10-20

1: Zuo M, Gao J, Zhang X, Cui Y, Fan Z, Ding M. Capillary electrophoresis with electrochemiluminescence detection for the simultaneous determination of cisatracurium besylate and its degradation products in pharmaceutical preparations. J Sep Sci. 2015 Jul;38(13):2332-9. doi: 10.1002/jssc.201500092. Epub 2015 May 13. PubMed PMID: 25872750.

2: Geng Z, Wu X. [Neuromuscular effects of cisatracurium besylate in obese patients]. Zhonghua Yi Xue Za Zhi. 2014 Sep 30;94(36):2844-6. Chinese. PubMed PMID: 25534104.

3: Dahaba AA, Suljevic I, Oettl K, Xiao Z, Dong H, Xiong L, Reibnegger G. Influence of acute normovolemic hemodilution on the pharmacokinetics of Cisatracurium Besylate. Minerva Anestesiol. 2013 Nov;79(11):1238-47. Epub 2013 May 23. PubMed PMID: 23698546.

4: Dahaba AA, Wang G, Xu X, Liu X, Wu X, Bornemann H, Metzler H. Influence of acute normovolaemic haemodilution on the dose-response relationship and time course of action of cisatracurium besylate. Br J Anaesth. 2007 Mar;98(3):342-6. Epub 2007 Jan 16. PubMed PMID: 17227819.

5: Imbeault K, Withington DE, Varin F. Pharmacokinetics and pharmacodynamics of a 0.1 mg/kg dose of cisatracurium besylate in children during N2O/O2/propofol anesthesia. Anesth Analg. 2006 Mar;102(3):738-43. PubMed PMID: 16492821.

6: de Ruiter J, Crawford MW. Dose-response relationship and infusion requirement of cisatracurium besylate in infants and children during nitrous oxide-narcotic anesthesia. Anesthesiology. 2001 May;94(5):790-2. PubMed PMID: 11388529.

7: Xu QA, Zhang YP, Trissel LA, Gilbert DL, Martinez JF, Fox JL. Stability of cisatracurium besylate in vials, syringes, and infusion admixtures. Am J Health Syst Pharm. 1998 May 15;55(10):1037-41. PubMed PMID: 9606456.

8: Zhang H, Wang P, Bartlett MG, Stewart JT. HPLC determination of cisatracurium besylate and propofol mixtures with LC-MS identification of degradation products. J Pharm Biomed Anal. 1998 Mar;16(7):1241-9. PubMed PMID: 9571542.

9: Jensen FS, Mogensen JV. [Cisatracurium besylate--Nimbex]. Ugeskr Laeger. 1998 Feb 2;160(6):858-60. Danish. PubMed PMID: 9469987.

10: Trissel LA, Martinez JF, Gilbert DL Jr. Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration. Am J Health Syst Pharm. 1997 Aug 1;54(15):1735-41. PubMed PMID: 9262747.